Two novel agents targeting angiopoietin-like protein 3 demonstrated safety and lipid-lowering capabilities in phase 2 trials, ...

Global Alpha Methyl Styrene (AMS) market was valued at USD 509 million in 2024 and is projected to reach USD 741 million by 2032, CAGR of 4.6% ...

Mosaic Therapeutics has secured the latest pieces in its combination medicine strategy by licensing two clinical stage tumor ...